Related references
Note: Only part of the references are listed.Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway
Jin Chai et al.
HEPATOLOGY (2012)
Canalicular ABC transporters and liver disease
Michael Nicolaou et al.
JOURNAL OF PATHOLOGY (2012)
NSAID Acyl Glucuronides and Enteropathy
Urs A. Boelsterli et al.
CURRENT DRUG METABOLISM (2011)
Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity
Antonello Di Paolo et al.
CURRENT DRUG METABOLISM (2011)
Decreased Hepatic Breast Cancer Resistance Protein Expression and Function in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats
Wei Yue et al.
DRUG METABOLISM AND DISPOSITION (2011)
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
John L. Wallace et al.
GASTROENTEROLOGY (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer
Linda J. M. Oostendorp et al.
ANTI-CANCER DRUGS (2010)
Familial cholestasis: Progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy
Wendy L. van der Woerd et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele
Jean-Baptiste Woillard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction The GEOSTAT-1 Study
Kristian M. Bailey et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Drug Uptake Systems in Liver and Kidney: A Historic Perspective
B. Hagenbuch
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
ABCC2/Abcc2: a multispecific transporter with dominant excretory functions
Katalin Jemnitz et al.
DRUG METABOLISM REVIEWS (2010)
Distribution of small intestinal mucosal injuries as a result of NSAID administration
Shunji Fujimori et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients
Zhang Wei Xia et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients
Erin L. Ohmann et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Differences in presentation and progression between severe FIC1 and BSEP deficiencies
Ludmila Pawlikowska et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatobiliary Disposition of Troglitazone and Metabolites in Rat and Human Sandwich-Cultured Hepatocytes: Use of Monte Carlo Simulations to Assess the Impact of Changes in Biliary Excretion on Troglitazone Sulfate Accumulation
Jin Kyung Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2010)
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
Christoph Schulz et al.
ANTI-CANCER DRUGS (2009)
ABCC2, ABCC3, and ABCB1, but not CYP3A, Protect against Trabectedin-Mediated Hepatotoxicity
Robert A. B. van Waterschoot et al.
CLINICAL CANCER RESEARCH (2009)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Incidence of Small Bowel Injury Induced by Low-Dose Aspirin: A Crossover Study Using Capsule Endoscopy in Healthy Volunteers
Hiroki Endo et al.
DIGESTION (2009)
OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids
Nazzareno Ballatori et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genetic Polymorphisms of MRP2 and UGT2B7 and Gastrointestinal Symptoms in Renal Transplant Recipients Taking Mycophenolic Acid
Jae Wook Yang et al.
THERAPEUTIC DRUG MONITORING (2009)
Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity
Jin Kyung Lee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Virus associated innate immunity in liver
Tatsuya Kanto
FRONTIERS IN BIOSCIENCE (2008)
Variability in human hepatic MRP4 expression: influence of cholestasis and genotype
U. Gradhand et al.
PHARMACOGENOMICS JOURNAL (2008)
Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
Masatomo Miura et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases
Sarah N. Barnes et al.
DRUG METABOLISM AND DISPOSITION (2007)
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
Ji-Youn Han et al.
CANCER (2007)
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex
S. Haenisch et al.
PHARMACOGENOMICS JOURNAL (2007)
Irinotecan-induced diarrhea: Functional significance of the polymorphic ABCC2 transporter protein
F. A. de Jong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
Ann K. Daly et al.
GASTROENTEROLOGY (2007)
Role of BCRP 421C>A polymorphism on rosuvastatin pharynacokinetics in healthy Chinese males
Wei Zhang et al.
CLINICA CHIMICA ACTA (2006)
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients
Maarten Naesens et al.
TRANSPLANTATION (2006)
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening:: A double-blind, randomized, placebo-controlled study
Floris A. De Jong et al.
ONCOLOGIST (2006)
Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis
A Mennone et al.
HEPATOLOGY (2006)
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides
N Zelcer et al.
JOURNAL OF HEPATOLOGY (2006)
The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins
AE van Herwaarden et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Microbial flora in NSAID-induced intestinal damage: A role for antibiotics?
A Lanas et al.
DIGESTION (2006)
A human transporter protein that mediates the final excretion step for toxic organic cations
M Otsuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
OSTα-OSTβ:: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia
N Ballatori et al.
HEPATOLOGY (2005)
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2
DA Hesselink et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene
M Hirouchi et al.
PHARMACEUTICAL RESEARCH (2005)
Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: In vitro evidence and effect of single nucleotide polymorphisms
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2005)
Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat
GU Denk et al.
JOURNAL OF HEPATOLOGY (2004)
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes:: A comparative analysis in paired tissue specimens
O von Richter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver
T Lang et al.
PHARMACOGENETICS (2004)
A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump
JRM Plass et al.
JOURNAL OF HEPATOLOGY (2004)
Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats
M Kobayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Functional analysis of SNPs variants of BCRP/ABCG2
C Kondo et al.
PHARMACEUTICAL RESEARCH (2004)
Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTα-OSTβ
DJ Seward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies
LM Shaw et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Tissue distribution and induction of human multidrug resistant protein 3
GL Scheffer et al.
LABORATORY INVESTIGATION (2002)
Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3
H Akita et al.
PHARMACEUTICAL RESEARCH (2002)
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes
K Bowalgaha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate
C Funk et al.
TOXICOLOGY (2001)
Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate
W Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
K Fattinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
T Hirohashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Genetic cholestasis: Lessons from the molecular physiology of bile formation
PLM Jansen et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance
T Kamisako et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Share Paper
